Výsledky vyhledávání - "Caroline Monchaud"

Akademický článek

The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation

Autor: Claire Villeneuve, PhD, Jean-Phillipe Rerolle, MD, Lionel Couzi, MD, PhD, Pierre-Francois Westeel, MD, Isabelle Etienne, MD, Laure Esposito, MD, Nassim Kamar, MD, PhD, Mathias Büchler, MD, PhD, Antoine Thierry, MD, PhD, Pierre Marquet, MD, PhD, Caroline Monchaud, PharmD, PhD

Publikováno v: Transplantation Direct, Vol 10, Iss 8, p e1678 (2024)

Background. In kidney transplant recipients with positive serology (R+) for the cytomegalovirus (CMV), 2 strategies are used to prevent infection, whose respective advantages over the other are still debated. This study aimed to evaluate the cost-eff

Externí odkaz: https://doaj.org/article/a99c81d097984fabb0eb049b9967d82f

Zobrazit plný text záznamu

Akademický článek

Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19

Autor: Lidvine Boland, Arnaud Devresse, Caroline Monchaud, Sébastien Briol, Stéphanie Belaiche, Baptiste Giguet, Lionel Couzi, Olivier Thaunat, Laure Esposito, Magdalena Meszaros, Ana Roussoulieres, Vincent Haufroid, Yannick Le Meur, Florian Lemaitre

Publikováno v: Transplant International, Vol 37 (2024)

Nirmatrelvir/ritonavir is a promising option for preventing severe COVID-19 in solid organ transplant recipients with SARS-CoV-2 infection. However, concerns have arisen regarding potential drug interactions with calcineurin inhibitors (CNI). This tw

Externí odkaz: https://doaj.org/article/56d6df7220e84d289aedfced940002a8

Zobrazit plný text záznamu

Akademický článek

Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?

Autor: Lien Haverals, MD, Laurence Roosens, PhD, Kristien Wouters, PhD, Pierre Marquet, MD, PhD, Caroline Monchaud, MD, PhD, Annick Massart, MD, PhD, Daniel Abramowicz, MD, PhD, Rachel Hellemans, MD, PhD

Publikováno v: Transplantation Direct, Vol 9, Iss 4, p e1439 (2023)

Background. Tacrolimus (Tac) has a narrow therapeutic range. Dosing is generally targeted at Tac trough levels (C0), notwithstanding conflicting reports on the correlation between Tac C0 and systemic exposure measured by the area-under-the-concentrat

Externí odkaz: https://doaj.org/article/49c343f9463c42208d6b61b0c4ac5740

Zobrazit plný text záznamu

Can the Area Under the Curve/Trough Level Ratio Be Used to Optimize Tacrolimus Individual Dose Adjustment?

Autor: Jean-Baptiste Woillard, Caroline Monchaud, Franck Saint-Marcoux, Marc Labriffe, Pierre Marquet

Publikováno v: Transplantation. 107(1)

The aim of this work was to evaluate, in a large data set of renal transplant recipients, the intraindividual variability of the area under the curve (AUC)/predose concentration (C0) ratio in comparison with that of AUC, C0, AUC/dose, and C0/dose.Pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da8a18eaed86b908d820fe685f04d33
https://pubmed.ncbi.nlm.nih.gov/36508648

Zobrazit plný text záznamu

Tacrolimus Bayesian Dose Adjustment in Pediatric Renal Transplant Recipients

Autor: Pierre Marquet, Jean-Baptiste Woillard, Ludovic Micallef, Florine Cros, Evelyne Jacqz-Aigrain, Franck Saint-Marcoux, Jean Debord, Caroline Monchaud

Publikováno v: Therapeutic Drug Monitoring. 43:472-480

BACKGROUND Immunosuppressant Bayesian Dose Adjustment (ISBA) is an online expert system that estimates the area under the curve (AUC) of immunosuppressive drugs through pharmacokinetic modelling and Bayesian estimation to propose dose adjustments to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efcdbfd0d958700aaa992f481e1abb02
https://doi.org/10.1097/ftd.0000000000000828

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání